HLA Haploidentical versus Matched Unrelated Donor Transplants with Post-Transplant Cyclophosphamide based prophylaxis
Key Points
Higher mortality with reduced intensity regimens after haploidentical relative compared to matched unrelated donor transplantation
Higher grade III-IV acute graft versus host disease after haploidentical relative compared to matched unrelated donor transplantation